| 1/4 | US=96 / Biol/Mol Berasain C, Castillo J, Perugorria MJ, Latasa MU, Pietro J, Avila MA. Inflammation and liver cancer. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 206-21. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0. CARCINOMA HEPATOCELULAR; INFLAMACAO; FATOR NUCLEAR-&*1181;B; NF-&*1181;B; STAT3; IL-6; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; AMPHIREGULIN; TOLL-LIKE RECEPTOR; TLR; RECONHECIMENTO DE RECEPTORES PADRAO; PRRS |
| 2/4 | US=84-A / Biol/Mol Yasui H, Hideshima T, Anderson KC. Transformig growth factor-B in developing and advanced cancers: inhibition of TGF-B signaling in multiple myeloma and its bone marrow microenvironment. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 219-27. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TGF-B; IL-6; VEGF; TGF-B RECEPTOR TIPO I; TBRI; MIELOMA MULTIPLO; MICROAMBIENTE DA MEDULA OSSEA; FATOR TRANSFORMADOR DE CRESCIMENTO; FACTOR DE CRESCIMENTO ENDOTELIAL VASCULAR; INIBIDOR DE QUINASE SD-208 |
| 3/4 | US=16 / Urologia Keller ET. Biology and imaging: biology and therapeutic basis of prostate cancer bone metastasis. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 175-91. (Contemporary Cancer Research) ISBN 978-1-58829-696-2. BIOLOGIA; IMAGEM; BASE TERAPEUTICA DE METASTASES OSSEAS; CANCER DE PROSTATA; ENDOTELINA-1; ET-1; IL-6; OPG; OSTEOPROTEGERINA; HORMONIO DA PARATIREOIDE; PTHRP; RANKL; RECEPTOR DO FATOR NUCLEAR-K B |
| 4/4 | US=47 / Clín/Medica Klouche M. Estrogens in human vascular diseases. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 431-43. ISBN 978-1-57331-699-5. ESTROGENIOS EM DOENCAS VASCULARES HUMANOS; ESTROGENIO; ANDROGENO; ERB; VASCULAR; MUSCULO LISO; IL-6; VEGF |